ETR vs RYTM · P/E 28, rev $12.95B vs rev $130.1M
Entergy Corporation (ETR) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the ETR and RYTM stock pages for the full models.
Not investment advice.